sb 203580 has been researched along with salicin in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (salicin) | Trials (salicin) | Recent Studies (post-2010) (salicin) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 257 | 6 | 107 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goto, M; Ishikado, A; Keith Blackwell, T; King, GL; Makino, T; Matsumoto, M; Okuno, A; Robida-Stubbs, S; Sono, Y | 1 |
1 other study(ies) available for sb 203580 and salicin
Article | Year |
---|---|
Willow bark extract increases antioxidant enzymes and reduces oxidative stress through activation of Nrf2 in vascular endothelial cells and Caenorhabditis elegans.
Topics: Animals; Antioxidant Response Elements; Antioxidants; Benzyl Alcohols; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Carboxylic Ester Hydrolases; Cells, Cultured; Cyclooxygenase Inhibitors; DNA-Binding Proteins; Endothelial Cells; Enzyme Activation; Enzyme Inhibitors; Glucosides; Glutamate-Cysteine Ligase; Glutathione; Heme Oxygenase-1; Human Umbilical Vein Endothelial Cells; Imidazoles; NF-E2-Related Factor 2; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Plant Bark; Plant Extracts; Proto-Oncogene Proteins c-myc; Pyridines; RNA Interference; RNA, Messenger; RNA, Small Interfering; Salix; Transcription Factors | 2013 |